Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2012
09/25/2012US8273784 Dinitropyrazole derivatives, their preparation, and energetic compositions comprising them
09/25/2012US8273783 Microbiocides
09/25/2012US8273782 Inhibitors of Akt activity
09/25/2012US8273781 Process for preparation of 1-alkyl-5-benzoyl-1H-tetrazole derivatives
09/25/2012US8273780 Polycyclic antagonists of lysophosphatidic acid receptors
09/25/2012US8273779 Thiazolidin 4-one derivatives
09/25/2012US8273778 Inhibitors of UDP-galactopyranose mutase thwart mycobacterial growth
09/25/2012US8273777 Glucokinase activators and methods of using same
09/25/2012US8273776 Biphenyl oxadiazole derivatives as sphingosine-1-phosphate receptors modulators
09/25/2012US8273774 Phenoxypyridinylamide compounds
09/25/2012US8273773 Heterocyclic antiviral compounds
09/25/2012US8273772 Heteroaryl compounds as P2Y1 receptor inhibitors
09/25/2012US8273771 Ischemic disorder or disease inhibitors
09/25/2012US8273770 5-pyridinone substituted indazoles
09/25/2012US8273769 Phenoxy acetic acid derivatives
09/25/2012US8273768 Iso CA-4 and analogues thereof as potent cytotoxic agents inhibiting tubuline polymerization
09/25/2012US8273767 Bicyclic-substituted amines as histamine-3 receptor ligands
09/25/2012US8273766 Tetrahydroisoquinoline compound
09/25/2012US8273765 Bicyclo-pyrazoles and pharmaceutical compositions comprising them
09/25/2012US8273763 Drugs for the treatment of sarcoglycanopathies
09/25/2012US8273762 Hexahydro-pyrrolo-isoquinoline compounds
09/25/2012US8273761 Tricyclic compound and medical use thereof
09/25/2012US8273760 Indolo[3,2-c]quinoline compounds
09/25/2012US8273758 Substituted tricyclic derivatives
09/25/2012US8273757 Combination of two analgesic chemicals
09/25/2012US8273756 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
09/25/2012US8273755 4-methylpyridopyrimidinone compounds
09/25/2012US8273754 Substituted 1H-pyrazolo[3,4-D]pyrimidine-6-amine compounds
09/25/2012US8273753 Polymorph B of N-{2-Fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a]pyrimidin-7-yl]-phenyl}-N-methyl-acetamide
09/25/2012US8273752 Substituted imidazopyrimidines and triazolopyrimidines
09/25/2012US8273749 N-substituted oxindoline derivatives as calcium channel blockers
09/25/2012US8273748 Amino alcohol derivative and immunosuppresive agent having same as an active ingredient
09/25/2012US8273747 tert-Butyl (4-((4'-cyano-4-methoxy-biphenyl-3-ylmethyl)-amino)-cyclohexyl)-methyl-carbamate; hedgehog pathway agonists; alopecia; angiogenesis; wound healing; alzheimer's disease; inhibit aging effects on skin
09/25/2012US8273746 Methods involving aldose reductase inhibitors
09/25/2012US8273745 Polycyclic acid compounds useful as CRTH2 antagonists and antiallergic agents
09/25/2012US8273744 AMPK modulators
09/25/2012US8273743 N-(4-chloro-3-(quinoxalin-3-yl)phenyl)-3,5-dimethoxybenzamide; for treating malignancies
09/25/2012US8273742 Disubstituted phthalazine hedgehog pathway antagonists
09/25/2012US8273740 antiallergen; not direct way to change nature of immunological response to allergen; G-protein-coupled "chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2)" antagonist for prostaglandin PGD2, that mediates PGD2-dependent migration of blood Th2 cells; ; asthma, rhinitis, COPD
09/25/2012US8273739 Method for the purification of mycophenolate mofetil
09/25/2012US8273738 Imidazole derivatives
09/25/2012US8273737 Quinolizidinone M1 receptor positive allosteric modulators
09/25/2012US8273736 Thienopyridine and furopyridine kinase inhibitors
09/25/2012US8273734 5HT2C receptor modulators
09/25/2012US8273733 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
09/25/2012US8273732 Compositions for combating beta-lactamase-medicated antibiotic resistance using beta-lactamase inhibitors useful for injection
09/25/2012US8273731 Compositions comprising nicotinic agonists and methods of using same
09/25/2012US8273730 Use of estriol in low doses
09/25/2012US8273729 Treatment of irritable bowel syndrome and related bowel disease
09/25/2012US8273728 Preformulation for tabletting natural mixtures of conjugated estrogens
09/25/2012US8273727 Lipid-analogous phosphoric triesters
09/25/2012US8273726 Compositions for treating and/or preventing diseases characterized by the presence of metal ions
09/25/2012US8273725 Stable hyaluronan/steroid formulation
09/25/2012US8273721 Combination treatment for bladder cancer
09/25/2012US8273720 6,11-bicyclolides: bridged biaryl macrolide derivatives
09/25/2012US8273719 Wrinkle-diminishing agent
09/25/2012US8273718 Composition for prevention or treatment of bone metabolism disorder comprising D-pinitol as an active ingredient
09/25/2012US8273717 Inhibitor for perioperative blood sugar elevation
09/25/2012US8273715 Methods of treating fragile X syndrome
09/25/2012US8273711 Topical drug delivery using phosphatidylcholine
09/25/2012US8273708 Regulation of paracellular permeability of the ocular surface epithelium, corresponding to the anterior segment of the eye; modulating the opening of tight junctions of the ocular epithelium; keratitis, conjunctivitis and dry eye syndrome
09/25/2012US8273685 Agrochemical composition
09/25/2012US8273390 Methods and compositions for administration of TRPV1 agonists
09/25/2012US8273383 Methods and compositions for treatment of preeclampsia
09/25/2012US8273380 Fortified beverage for minimizing and/or preventing jet lag
09/25/2012US8273379 Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol
09/25/2012US8273378 Dialysis solutions containing pyrophosphates
09/25/2012US8273375 Targeted, efficient release; dosing accuracy, well distributed in intestinal lumen; lipophilic matrix providing bioavailability
09/25/2012US8273373 Photocrosslinked biodegradable hydrogel
09/25/2012US8273363 Cancer cell targeting using nanoparticles
09/25/2012US8273353 Inhibitors of vascular endothelial growth factor activity
09/25/2012US8273349 Binding member which binds to both lewis-Y and lewis-B haptens, and its use for treating cancer
09/25/2012US8273345 Targeted gene delivery to dendritic cells
09/25/2012US8273342 Anti-virus therapy for respiratory diseases
09/25/2012US8273341 Antiviral compounds
09/25/2012US8273339 Polymer-based compositions and conjugates of antimicrobial agents
09/25/2012US8273338 Treatment and composition for achieving skin anti-aging benefits by corneum protease activation
09/25/2012US8273331 Combination of medicament and lactose particles; accurate, uniform, consistent dispersion for multidose dry powder inhaler
09/25/2012US8273324 Embolization
09/25/2012CA2771537A1 Composition, synthesis, and use of new substituted pyran and pterin compounds
09/25/2012CA2716948C Pharmaceutical composition and poria extract useful for enhancing absorption of nutrients
09/25/2012CA2683124C Aminoalkoxy aryl sulfonamide compounds and their use as 5-ht6 ligands
09/25/2012CA2683059C Atropisomer of pyrrole derivative
09/25/2012CA2683040C Polymorphic forms of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride
09/25/2012CA2679530C Benzimidazole compound and pharmaceutical use thereof
09/25/2012CA2667481C New phenylsulfamoyl benzamide derivatives as bradykinin antagonists
09/25/2012CA2667285C New sulfonamide derivatives as bradykinin antagonists
09/25/2012CA2648109C Combination of an anti-ed-b fibronectin domain antibody-il-2 fusion protein and gemcitabine
09/25/2012CA2641744C Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors
09/25/2012CA2616079C Novel heterocyclidene acetamide derivative
09/25/2012CA2593264C Bicyclic pyrimidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
09/25/2012CA2567400C Solid pharmaceutical formulation
09/25/2012CA2560071C Lysine based compounds
09/25/2012CA2557371C Crystalline forms of a pharmaceutical compound
09/25/2012CA2554679C Prophylactic or therapeutic agent for diabetic maculopathy
09/25/2012CA2553510C Aromatic a-ring derivatives of tetracycline compounds
09/25/2012CA2547654C Use of osteopontin in dental formulations
09/25/2012CA2538939C Selective estrogen receptor modulators
09/25/2012CA2532804C Substituted 2-aminotetralin for the treatment of depression
09/25/2012CA2529984C Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors
1 ... 1032 1033 1034 1035 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 ... 7860